Prediction and identification of B cell epitopes derived from EWS/FLI-l fusion protein of Ewing’s sarcoma
First Online: 06 May 2012 Received: 11 January 2012 Accepted: 17 April 2012 DOI:
10.1007/s12032-012-0243-7 Cite this article as: Liu, H., Huang, L., Luo, J. et al. Med Oncol (2012) 29: 3421. doi:10.1007/s12032-012-0243-7 Abstract
To predict B cell epitope of Ewing’s sarcoma EWS/FLI-l fusion protein and to analyze its antigenicity and immunogenicity. Comprehensive algorithms were applied to predict the possible B cell epitopes of EWS/FLI-l fusion protein. High-performance liquid chromatography (HPLC) and mass spectrometry (MS) analysis were performed to identify the synthesized epitope peptides, ELISA assays and Western blot to detect the antigenicity, and the immunogenicity of epitope peptides. Three B cell epitopes were screened out, and HPLC and MS analysis confirmed all three synthesized epitope peptides were demandable. ELISA assays verified all three epitope peptides could prime intense antigen–antibody reaction and induce ideal antibody titers after immunization to the New Zealand white rabbit. However, Western blot confirmed that antiserum of one of these epitope peptides could not recognize EWS/FLI-1 protein. Two B cell epitopes, PQDGNKPTETSQPQ and DPDEVARRWGQRKS, derived from EWS/FLI-l protein, are identified to have potential antigenicity and immunogenicity.
Keywords Ewing’s sarcoma EWS/FLI-l fusion protein B cell epitope Antigenicity Immunogenicity
Huiwen Liu and Lu Huang are equally contributed to this paper.
Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003;348:694–701.
Barker LM, Pendergrass TW, Sanders JE, et al. Survival after recurrence of Ewing’s sarcoma family of tumors. J Clin Oncol. 2005;23:4354–62.
Rodriguez-Galindo C, Spunt SL, Pappo AS. Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. Med Pediatr Oncol. 2003;40:276–87.
Chansky HA, Barahmand-Pour F, Mei Q, et al. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing’s sarcoma cells in vitro. J Orthop Res. 2004;22:910–7.
Hu-Lieskovan S, Heidel JD, Bartlett DW, et al. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing’s sarcoma. Cancer Res. 2005;65:8984–92.
Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med. 2004;10(9):909–15.
Qi CJ, Ning YL, Han YS, et al. Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer. Cancer Immunol Immunother. 2012. doi:
Onishi H, Morisaki T, Baba E, et al. Long-term vaccine therapy with autologous whole tumor cell-pulsed dendritic cells for a patient with recurrent rectal carcinoma. Anticancer Res. 2011;31(11):3995–4005.
Kantoff PW, Higano CS, Shore ND, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med. 2010;363(5):411–22.
de Alava E, Gerald WL. Molecular biology of the Ewing’s sarcoma/primitive neuroectodermal tumor family. J Clin Oncol. 2000;18:204–13.
Kovar H. Ewing’s sarcoma and peripheral primitive neuroectodermal tumors after their genetic union. Curr Opin Oncol. 1998;10:334–42.
Le Deley MC, Delattre O, Schaefer KL, et al. Impact of EWS-ETS fusion type on disease progression in Ewing’s sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial. J Clin Oncol. 2010;28(12):1982–8.
Arvand A, Denny CT. Biology of EWS/ETS fusions in Ewing’s family tumors. Oncogene. 2001;20(40):5747–54.
Goldsby RA, Kindt TJ, Kuby J, et al. Immunology. 5th ed. New York: W. H. Freeman; 2002.
Meyer-Wentrup F, Richter G, Burdach S. Identification of an immunogenic EWS-FLI1-derived HLA-DR-restricted T helper cell epitope. Pediatr Hematol Oncol. 2005;22:297–308.
Zhao J, Huang L, Chen W, et al. Prediction, screening and identification of HLA-A2.1-restricted CTL epitopes derived from Ewing’s sarcoma EWS-FLI1 fusion protein. The Journal of Immuology. 2010;26:10–5. (Chinese).
Cao K, Huang L, Lin ZH, et al. Screening of HLA-A2.1-restricted CTL epitopes derived from Ewing’s sarcoma EWS-FLI1 fusion protein by using molecular simulation. Acta Chim Sinica. 2010;68:1277–84.
Garnier J, Robson B. The GOR method for predicting secondary structures in proteins. In: Fasman GD, editor. Prediction of Protein Structure and the Principles of Protein Conformation. New York: Plenum Press; 1989. p. 417–65.
Chou PY, Fasman GD. Empirical predictions of protein conformation. Annu Rev Biochem. 1978;47:251–76.
Eisenberg D. The discovery of the alpha-helix and beta-sheet, the principal structural features of proteins. Proc Natl Acad Sci. 2003;100(20):11207–10.
Jameson BA, Wolf H. The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci. 1988;4:181–6.
Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982;157(1):105–32.
Emmini EA, Hughes JV, Perlow DS, et al. Induction of hepatitis a virus-neutralizing antibody by a virus-specific synthetic peptide. J Viorol. 1985;55(3):836–9.
Karplus PA, Schulz GE. Prediction of chain flexibility in proteins. Naturwissenschaften. 1985;72(4):212–3.
Chen W, Huang L, Huang S, et al. The Construction And Identification Of Prokaryotic Expression Vector pQE30-EWS-FLI1. J Chongqing Med Univers. 2010;35:645–8. (Chinese).
Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol. 2005;5(4):296–306.
Ackermann B, Tröger A, Glouchkova L, et al. Characterization of CD34 + progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis. Klin Padiatr. 2004;216(3):176–82.
Tang S, Guo W, Guo Y, et al. In vitro antitumor immune response induced by fusion of dendritic cells and Ewing’s sarcoma cells. Zhonghua Wai Ke Za Zhi. 2005;43(12):803–6. (Chinese).
Qu HY, Guo W, He XJ. Construction of recombinant adenoviral vector containing gene of EWS-FLI1 and antitumor immunity of its modified dentritic cell in vitro. Beijing Da Xue Xue Bao. 2006;38(6):623–7. (Chinese).
Guo W, Guo Y, Tang S, et al. Dendritic cell-Ewing’s sarcoma cell hybrids enhance antitumor immunity. Clin Orthop Relat Res. 2008;466(9):2176–83.
Zaiss AK, Liu Q, Bowen GP, et al. Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J Virol. 2002;76(9):4580–90.
Nardin EH, Calvo-Calle JM, Oliveira GA, et al. A totally synthetic polyoxime malaria vaccine containing plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types. J Immunol. 2001;166:481–9.
Dakappagari NK, Pyles J, Parihar R, et al. A chimeric multi-human epidermal growth factor receptor-2 B cell epitope peptide vaccine mediates superior antitumor responses. J Immunol. 2003;170:4242–53.
Valmori D, Souleimanian NE, Hesdorffer CS, et al. Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses. Clin Immunol. 2005;117:24–30.
Gaseitsiwe S, Valentini D, Mahdavifar S, et al. Peptide Microarray-Based Identification of Mycobacterium tuberculosis Epitope Binding to HLA-DRB1*0101, DRB1*1501, and DRB1*0401. Clin Vaccine Immunol. 2009;17(1):168–75.
Linnebacher M, Lorenz P, Koy C, et al. Clonality characterization of natural epitope-specific antibodies against the tumor-related antigen topoisomerase IIa by peptide chip and proteome analysis: a pilot study with colorectal carcinoma patient samples. Anal Bioanal Chem. 2012;403(1):227–38.
Paes C, Ingalls J, Kampani K, et al. Atomic-Level Mapping of Antibody Epitopes on a GPCR. J Am Chem Soc. 2009;131(20):6952–4.
Zhang ZW, Zhang YG, Wang YL, et al. Screening and identification of B cell epitopes of structural proteins of foot-and-mouth disease virus serotype Asia1. Vet Microbiol. 2010;140(1–2):25–33.
Yang JM, Wang HJ, Du L, et al. Screening and identification of novel B cell epitopes in human heparanase and their anti-invasion property for hepatocellular carcinoma. Cancer Immunol Immunother. 2009;58(9):1387–96.
Cao K, Huang L, An H, et al. Prediction for secondary structure and B cell epitopes of fusion region in EWS-FLI1 protein of Ewing’s sarcoma. J Chin immunol. 2008;24:11–5. (Chinese).
Staege MS, Gorelov V, Bulankin A, et al. Stable transgenic expression of IL-2 and HSV1-tk by single and fusion tumor cell lines bearing EWS/FLI-1 chimeric genes. Pediatr Hematol Oncol. 2003;20:119–40.
Loughran ST, Walls D. Purification of poly-histidine-tagged proteins. Methods Mol Biol. 2011;681:311–35.
PubMed CrossRef Copyright information
© Springer Science+Business Media, LLC 2012